Citizens JMP initiates Performant Healthcare stock with Market Outperform rating

Published 10/07/2025, 09:12
Citizens JMP initiates Performant Healthcare stock with Market Outperform rating

Investing.com - Citizens JMP initiated coverage on Performant Healthcare Inc (NASDAQ:PHLT) with a Market Outperform rating and a price target of $8.00. The stock, currently trading at $4.28, has shown impressive momentum with a 70% surge over the past six months. According to InvestingPro data, the company maintains a healthy financial position with a current ratio of 2.56.

The research firm projects Performant Healthcare will deliver the fastest profit growth in its healthcare technology and services coverage universe, with adjusted EBITDA estimates of $9.5 million for 2025 (up 117% year-over-year), $21.0 million for 2026 (up 121%), and $30.0 million for 2027 (up 43%). This growth trajectory aligns with InvestingPro analysis, which indicates strong revenue growth of 11.76% and two analysts revising earnings estimates upward for the upcoming period.

Citizens JMP’s 2025 and 2026 adjusted EBITDA estimates exceed the current consensus expectations of $9.3 million and $18.5 million, respectively, with the firm modeling an adjusted EBITDA compound annual growth rate of 78% from 2025 to 2027.

The $8.00 price target is based on applying a 30x multiple to the firm’s 2026 adjusted EBITDA estimate, with PHLT recently trading at 35.6x and 16.1x the 2025 and 2026 estimates.

Citizens JMP justifies the multiple based on Performant Healthcare’s scarcity value, projected profit growth, potential for longer-term margin improvement, and the favorable secular backdrop for payment integrity programs under the current Presidential Administration.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.